Growing Market for Smoking Cessation and Nicotine Withdrawal Products

Jul.19.2022
The smoking cessation market has grown with innovations in products and increased awareness of health risks, expected to reach $27.84 billion by 2031.

According to analysis of smoking cessation industry statistics from the past few decades by TMR market research company, the use of smoking cessation products to help smokers quit has increased, primarily including skin patches and oral products. The smoking cessation and nicotine withdrawal market is expected to reach $27.84 billion by 2031. The target audience is becoming more aware of the health burden associated with smoking, as smoking-related illnesses lead to premature deaths every year.


Innovative marketing campaigns that promote the availability and effectiveness of various smoking cessation products have raised awareness of the benefits of quitting smoking, leading to an expansion of the market for tobacco cessation and nicotine replacement companies. National research institutions in the United States and United Kingdom are heavily supporting research on tobacco-related diseases. Due to these factors and market trends, smoking cessation programs in Europe have seen significant growth, expanding the market for smoking cessation products.


A series of studies have emphasized the effectiveness of e-cigarettes in smoking cessation therapy, which has broadened the perspective of the smoking cessation and nicotine withdrawal market. Over the years, the number of young people seeking to quit smoking has significantly increased, which has expanded commercial avenues for gum, lozenges, inhalers, nasal sprays, and nicotine patches. The target audience's understanding of smoking cessation products through online channels has also been increasing, which has promoted the growth of the smoking cessation and nicotine withdrawal market.


The primary findings of the market research on smoking cessation and nicotine withdrawal.


Increased demand for both over-the-counter (OTC) and prescription products, including those designed to alleviate the health burdens of smoking and nicotine, is being driven by a focus on reducing smoking- and nicotine-related health issues. This demand has also spurred growth in the nicotine replacement therapy (NRT) market, which has become an effective tool for smoking cessation and nicotine addiction treatment. Over the past several decades, new smoking cessation aids have been introduced to the market, particularly in the US and UK. Notably, e-cigarettes play a crucial role in smoking cessation, with companies relying on advances in nicotine technology to convince smokers to successfully switch to vaping.


The widespread sales of nicotine replacement therapy (NRT) products driving income growth: For many years, NRT products have been widely adopted in key markets such as the United States. A business intelligence study by TMR found that NRT lozenges, patches, and gum have increased in commercialization in the smoking cessation and nicotine withdrawal market. Additionally, in 2020, NRT product sales saw significant growth in Europe and North America, driving market growth for smoking cessation and nicotine addiction treatment.


Smoking and Nicotine Cessation Market: Key Drivers


The increasing burden of health issues caused by tobacco and nicotine products is a key driver in the market. It is important to note that smoking-related illnesses lead to millions of premature deaths each year.


Electronic cigarettes are becoming increasingly popular and are beneficial for users who want to quit smoking. Their effectiveness is enhanced when used in conjunction with counseling, behavioral therapy, and medication. There is a growing market for smoking cessation products and nicotine replacement therapy (NRT) products that are expanding the avenues for quitting smoking and overcoming nicotine addiction.


In 2020, North America took a leading position in the global smoking cessation and nicotine withdrawal market, with the United States offering significant revenue opportunities for market participants.


Europe is another lucrative market region. Over the years, the implementation of anti-smoking initiatives in certain areas and the rapid adoption of nicotine-containing smoking cessation products have created a significant source of revenue.


The Asia-Pacific region is witnessing a colossal market, and noteworthy is the incredible untapped avenue that manufacturers of NRT (nicotine replacement therapy) products are discovering in the region.


I am sorry, I cannot do that as the original text in unclear. Please provide me with the text you want me to translate.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Florida HB 389 seeks statewide ban on smoking and vaping in public places and indoor workplaces
Florida HB 389 seeks statewide ban on smoking and vaping in public places and indoor workplaces
Florida lawmakers have introduced HB 389, a proposal to expand smoke-free protections by banning smoking and vaping in public places and enclosed indoor workplaces across the state. The bill broadens statutory definitions and outlines limited exceptions and compliance rules, with an effective date of July 1, 2026 if enacted.
Feb.10 by 2FIRSTS.ai
Altria Reports Full-Year 2025 Results: Revenue Down 3.1%, Cigarette Volumes Slide 10% as NJOY Takes Impairment Hit
Altria Reports Full-Year 2025 Results: Revenue Down 3.1%, Cigarette Volumes Slide 10% as NJOY Takes Impairment Hit
Altria has released its full-year 2025 results, reporting full-year net revenues of $23.279 billion, down 3.1% year over year. Domestic cigarette shipment volume fell 10% for the year. on! nicotine pouches reached a 7.7% share of the U.S. oral tobacco category in the fourth quarter. NJOY posted $21 million in net revenues in Q4, while full-year net revenues were negative $13 million (mainly due to returns and related factors).
Jan.30 by 2FIRSTS.ai
BAT CEO Says 2026 Return to Growth Hinges on U.S. Enforcement, Highlights Oral Leadership
BAT CEO Says 2026 Return to Growth Hinges on U.S. Enforcement, Highlights Oral Leadership
British American Tobacco said 2026 will mark a return to its mid-term growth algorithm, but CEO Tadeu Marroco stressed that deliverywill depend heavily on enforcement against illicit vapour products in the United States. Speaking at the FY2025 results call, he positioned Modern Oral as the company’s primary structural growth engine, reframed accelerating cigarette declines through “poly-usage,” and reinforced capital discipline with an expanded share buyback plan.
Feb.12
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Marty Makary briefly appeared at the February 10 PMTA roundtable, underscoring the importance of regulatory predictability. At the close of the session, Office of Science Director Matthew Farrelly responded to industry concerns over review uncertainty, stating the agency will issue a written summary of feedback, while reiterating that no fixed quantitative risk benchmark governs authorization decisions.
Feb.11
Exclusive | EU Confirms End of Tobacco Policy Expert Group, Explores New Cooperation Structures as TPD Revision Continues
Exclusive | EU Confirms End of Tobacco Policy Expert Group, Explores New Cooperation Structures as TPD Revision Continues
2Firsts reporting shows that, as the European Union moves toward a future evaluation of its tobacco legislation, the Tobacco Policy Expert Group—long a key platform for coordination among Member States—formally concluded its mandate at the end of 2025. At the same time, the European Commission is exploring new cooperation structures to address the resulting institutional gap.
Jan.22
Juul, NJOY and Altria Clash Over Use of UCSF Public Documents in U.S. Patent Litigation
Juul, NJOY and Altria Clash Over Use of UCSF Public Documents in U.S. Patent Litigation
Juul Labs has asked a U.S. federal court to prevent NJOY and Altria from using documents stored in a public UCSF database in an ongoing patent lawsuit, arguing they are protected by attorney–client privilege. The defendants say the files have long been public and may contain evidence relevant to Juul’s patent conduct.
Dec.29 by 2FIRSTS.ai